NCT07354594
- Conditions
- Prostate Cancer Metastatic Castration-Resistant
- Locations
-
- Centre Hospitalier de l'Université-de-Montréal Montreal, Quebec, Canada
Clinical trial condition
Prostate Cancer Metastatic Castration-Resistant
Explore clinical trials studying Prostate Cancer Metastatic Castration-Resistant. Study availability and eligibility vary by location and protocol.
4 public trials
3 recruiting studies
Prostate Cancer Metastatic Castration-Resistant trial results
NCT07179783
- Conditions
- Adenocarcinoma, Carcinoma, Genital Diseases, +14 more
- Locations
-
- Tianjin Medical Unversity Second Hospital Tianjin, Tianjin Municipality, China
Recruiting
Liquid Biopsy Under PSMA Radioligand Therapy
NCT07118436
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
- Locations
-
- University hospital Wuerzburg - Department of Nuclear Medicine Augsburg, Germany
- TUM Klinikum rechts der Isar - Department of Nuclear medicine München, Germany
- University hospital Wuerzburg - Department of Nuclear Medicine Würzburg, Germany
Active, not recruiting
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
NCT03012321
- Conditions
- Abnormal DNA Repair, Genital Diseases, Genital Diseases, Male, +11 more
- Locations
-
- University of California Los Angeles Los Angeles, California, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Northwestern Medicine Chicago, Illinois, United States
- Rush University Cancer Center Chicago, Illinois, United States